Four sources of error associated with virus-specific immunoglobulin M (IgM) determination by indirect enzyme-linked immunosorbent assay were recognized and analyzed. First, competitive inhibition due to specific IgG was demonstrated by experiments involving addition and subtraction of rubella-specific IgG. Second, the interference due to rheumatoid factors (RFs) of the IgM class (IgM-RFs) was studied thoroughly, and it appeared that the level of false positivity was more dependent on specific IgG titers than on IgM-RF titers. 
Four sources of error associated with virus-specific immunoglobulin M (IgM) determination by indirect enzyme-linked immunosorbent assay were recognized and analyzed. First, competitive inhibition due to specific IgG was demonstrated by experiments involving addition and subtraction of rubella-specific IgG. Second, the interference due to rheumatoid factors (RFs) of the IgM class (IgM-RFs) was studied thoroughly, and it appeared that the level of false positivity was more dependent on specific IgG titers than on IgM-RF titers. Third, it was found that some IgM-RFs, differing from conventional IgM-RFs in that they reacted only with isologous IgG, were responsible for further cases of false positivity. Fourth, the interference of an IgM reacting with some virus-unmasked cellular antigens was demonstrated for some uninfected individuals. AU four interfering factors could be readily eliminated by simply premixing serum samples with a sheep anti-human gamma-chain serum. This single pretreatment was shown to eliminate false-negatives as well as false-positives in a further 2,004 sera tested for six viruses. These results also emphasize the frequency of RFs and their heterogeneity.
Demonstration of virus-specific antibodies of the immunoglobulin M (IgM) class appears to be a precious and reliable indicator of current or recent infection. The small amount of antibodies of this class relative to specific IgG calls for assays of high sensitivity, such as enzyme-linked immunosorbent assays (ELISAs). Indirect ELISA, in which the solid phase is coated with the viral antigen, has been used for its ease in demonstrating specific IgM as well as IgG and IgA. However, IgM demonstration is frequently hampered by the attachment of rheumatoid factor (RF) of the IgM class (IgM-RF) to specific IgG, leading to a positive reaction in the absence of specific IgM.
Various techniques for elimination of RF-related nonspecific positivities have been tried. They only partially eliminate RF: aggregated IgG (16), IgG-coated latex particles (20) , and Staphylococcus aureus protein A (7) or protein A-Sepharose saturated with IgG (11, 17) . IgG immunoprecipitation has been recommended for immunofluorescence assays by Gispen et al. (9) ELISA for IgM-RF and antibodies to viruses. Dilution of all sera was performed in 0.01 M phosphate-buffered saline (pH 7.4) containing 4% Tween 20 and 2% bovine serum albumin. Microplates were washed in the same buffer lacking albumin in a Titertek automatic washer (Flow Laboratories, Inc.). Sodium carbonate-bicarbonate, 0.05 M, pH 9.6, was used as a coating buffer. Phosphatase-labeled rabbit antisera to human gamma and mu chains (whole antibody) (Behring) were used in all ELISAs, except in an experiment shown in Fig. 4 , for which an F(ab')2 goat anti-human mu chain was necessary (Tago, Burlingame, Calif.). Microplates, Ushaped, were coated with either rubella, mumps, CMV, measles, varicella-zoster virus (VZV), or HSV antigens or with control antigen, i.e., uninfected cells prepared in the same way as viral antigens: BHK-21 cells for rubella, Vero cells for mumps, HeLa cells for HSV, and human embryonary fibroblasts for VZV, CMV, and measles (Enzygnost; Behring). For IgM-RF determination, U-shaped microplates (Nunc immunoplate Il; Roskilde, Denmark) were coated with human IgG (Nordic, Tilburg, The Netherlands), 0.1 ptg/ml, and saturated with a 4% bovine serum albumin solution. Sera were tested in duplicate; no control antigen could be used. Determination of autologous IgM-RF was performed similarly but on plates coated with a rabbit anti-human gamma-chain serum (Dako), 1:250.
Enzyme immunoassays were performed as described previously (3) (4) (5) and as follows: 100 ,ul of untreated or pretreated serum was added to virus-and control antigen-coated wells and incubated for 60 min at 37°C; after the washing, anti-gamma-or anti-mu-chain conjugates were distributed in corresponding wells and incubated similarly. After the washing, para-nitrophenyl phosphate substrate was distributed and incubated for 45 min; absorbancy was measured at 405 nm in a Multiskan photometer (Flow Laboratories).
For specific immunoglobulin quantitation, a Commodore computer, running homemade software, was directly connected to the photometer. For viral assays, but not necessary for IgM-RF determinations, the absorbancy of sera on control antigen was subtracted from the absorbancy on viral antigen (net absorbancy). The net absorbancy of each test serum was compared with that of control sera for determination of titer. For calibration, positive control sera were serially diluted twofold, starting at 1:100, and all dilutions were tested; a standard dose-response curve, plotting the absorbance values against the dilutions, was then calculated by the regression analysis method. An A405 cutoff value of 0.200 was necessary to assess positivity, and negative sera were regularly under an A405 of 0.070; for rubella IgG, the threshold corresponded to 10 IU; for IgM-RF, to 4 IU; for viral IgM, to 1 U (arbitrary unit); and for other virus-specific IgGs, to a titer of 100 (dilution of test sera, 1:100). The titer of each test serum was deduced by comparison of its net absorbancy with that of the serially diluted control serum.
RESULTS
Effect of rubella-specific IgG on the sensitivity of determination of rubella IgM. The influence of the simultaneous presence of specific IgG on specific IgM titers was studied in a rubella ELISA. Levels of rubella-specific IgG and IgM were determined in 10 mixtures containing a constant concentration of specific IgM and increasing amounts of rubellaspecific IgG from 0 to 2,560 IU. With rubella-specific IgM at 1 and 2 U, it was observed that the measured apparent IgM titer could be much lower than the expected titer or even negative when high quantities of specific IgG were simultaneously present (Fig. 1A and B) .
Conversely, progressive IgG immunoprecipitation in a serum containing rubella-specific IgM demonstrated a rise in specific IgM titers. Serum from a patient with rubella, containing 640 IU of rubella-specific IgG and 64 U of rubella-specific IgM but devoid of IgM-RF, was pretreated with serial twofold dilutions of anti-gamma-chain serum. Results of a typical experiment are reported in Fig. 2 . They clearly show that the IgM titer was minimal, 8 U, when all IgGs were present and dramatically increased up to 64 U as soon as specific IgGs were immunoprecipitated.
Effect of rubella-specific IgG and IgM-RF on the specificity of the determination of rubella IgM. It was demonstrated, by varying the amount of rubella-specific IgG and IgM-RF (Fig.  3) , that reactivity in the IgM ELISA could be observed although all the mixtures were devoid of rubella-specific IgM. The degree of this false positivity in IgM was proportional to the concentrations of both rubella-specific IgG and IgM-RF. It appears clearly that in this built-up experiment a proper combination of both components is necessary to obtain false positivity. Thus Competition between IgG and IgM was demonstrated by progressive addition, as well as by progressive subtraction, of specific IgG relative to specific IgM. Low levels of specific IgM may even become no longer detectable by the assay when specific IgGs are concomitantly present, as in Fig. 2 . In such a situation, it is difficult to distinguish between antigen limitation and the different accessibility, diffusibility, avidity, and affinity of the various classes of specific antibodies.
The role of IgM-RF in false positivity in specific IgM determination by ELISA was confirmed in this study (8, 14, 18) . However, we observed that the level of specific IgG had more influence than the level of RF on the resulting false positivity. As measured by the slopes of the false-positive results (Fig. 3) , the affinity of RF for complexed IgG was 1.5-fold weaker than that of IgG for the antigen. Thus, in the presence of low titers of specific IgG, the influence of RF was not perceptible. This explains why 339 of the 2,004 sera with an IgM-RF titer of >4 IU did not give rise to false positivity. Vejtorp (18) had determined that false-positive results were produced with IgM-RF titers of >3.5 IU/ml if rubella IgG titers were >30 IU/ml, but the cutoffwas an A405 of 0.040; in our assay an IgM-RF titer of 32 IU was necessary for a cutoff of 0.200. The prevalence of IgM-RF above 4 IU in our series was not significantly different in virus-infected and noninfected patients; however, it was 5.6 versus 3.4%, respectively, for titers of >32 IU. Salonen et al. (14) observed a higher prevalence of IgM-RF in rubella and influenza patients than in controls or patients with six other viral infections.
A number of false-positive results could not be related to the presence of IgM-RF since RF titers, i.e., their reactivity on a pool of aggregated human IgG, were insignificant. However, we found in these sera some IgM with specificity restricted to autologous complexed IgG and thus different from the classic IgM-RF. Such cases of strictly autologous IgM-RF were infrequent, 21 among the 1,800 tested (ca. 1%).
Lastly, a few false-positive reactions, also occurring in individuals negative for viral isolation and for clinical symptoms, were attributable to some IgM which, although not virus specific, still reacted more strongly with virus-infected cells than with control antigen. Such IgMs were not antinuclear antibodies, and adsorption and agglutination studies showed that they were not of the Forssman or infectious mononucleosis heterophile type. Thus, only 4 of 1,800 individuals (0.2%) had such an autoantibody, a natural IgM directed against a ubiquitous antigen hidden in human and simian cultured cells, where it is unmasked when they are infected by a virus, and also unexpectedly present in sheep serum. It is relevant to notice that Cunliffe et al. (6) reported that some murine IgM reacted with isologous murine bromelain-treated erythrocytes.
Further work will be necessary to explain why sera, either with autologous IgM-RF or with IgM to virus-unmasked antigen, should become negative following pretreatment. serum for the pretreatment described here. This serum must be devoid of antiviral activity lest it block antigenic sites on the solid phase and lower assay sensitivity. Second, the working dilution of anti-gamma-chain serum must be sufficient to neutralize physiological levels of IgG: here we used a fourfold excess. Consequently, the treated serum contains the immunoprecipitate and some anti-IgG in excess; neither was found to interfere in any way with the viral ELISA, and there is no theoretical reason why they should. In the IgM-RF assay, the unexpected positivity observed in Fig. 4 , when the anti-IgG serum was used pure, may be explained by the excess of antiserum which readily bound the plasticadsorbed human IgG and also captured the anti-mu-chain rabbit conjugate, this probably because of a heterologous human-rabbit activity. Indeed, simply using an F(ab')2 rabbit conjugate made the reaction return to normal, i.e., negative. Anyway, pretreatment is pointless in IgM-RF assays. More generally, this simple and efficient method could be used as an alternative to ultrafiltration or centrifugation for serum fractionation whenever a specific activity is to be demonstrated in the IgM or IgA class independently of IgG for neutralization, hemagglutination inhibition, passive hemagglutination, or complement fixation tests.
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